Bank Maspion Indonesia Tbk. vs Diagnos Laboratorium Utama Tbk. — how do they compare? Bank Maspion Indonesia Tbk. trades at Rp476 (market cap 8.49T, 6.6K 24h volume), while Diagnos Laboratorium Utama Tbk. trades at Rp224 (market cap 310.75B, 963.6K 24h volume). The key difference: Bank Maspion Indonesia Tbk. is far larger — about 27.3× Diagnos Laboratorium Utama Tbk.'s market cap, and Diagnos Laboratorium Utama Tbk. is more actively traded (963.6K versus 6.6K). Which is the better fit depends on your goals.
| BMAS | DGNS | |
|---|---|---|
Market Cap | 8.49T | 310.75B |
Volume | 6.6K | 963.6K |
Lot | 66 | 9.64K |
Turnover | 3.12M | 217.67M |
Average Price | 472.15 | 225.89 |
Value | 3.12M | 217.67M |
Indicative Equilibrium Price | — | 226 |
Indicative Equilibrium Volume | — | 1K |
Trailing returns across standard periods
Latest headlines on both assets
PT Bank Maspion Indonesia Tbk (the Bank) was established on November 6, 1989 based on Notarial Deed No. 68 of Soetjipto, S.H., which was amended by Notarial Deed No. 49 dated December 5, 1989 of the same notary. The Bank started its commercial operations in 1990. As of December 31, 2012, the Bank has 10 domestic branches, 27 sub-branches, 10 cash offices and 45 Automatic Teller Machines (ATMs) located at Surabaya, Jakarta, Semarang, Denpasar, Medan, Bandung, Makassar, Malang, Solo and Purwokerto.
Read more on BMAS →PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.
Read more on DGNS →